new england journal medicine

publicité

publicité

Documents connexes

NEWS IN BRIEF Neratinib Graduates to I-SPY 3

NEWS IN BRIEF Neratinib Graduates to I-SPY 3

I-SPY 2 — Toward More Rapid Progress in Breast Cancer Treatment

I-SPY 2 — Toward More Rapid Progress in Breast Cancer Treatment

A STUDY OF PLUS CAPECITABINE VERSUS LAPATINIB PLUS CAPECITABINE IN PATIENTS WITH

A STUDY OF PLUS CAPECITABINE VERSUS LAPATINIB PLUS CAPECITABINE IN PATIENTS WITH

I-SPY 2 Shows Efficacy of T-DM1-Pertuzumab.docx

I-SPY 2 Shows Efficacy of T-DM1-Pertuzumab.docx

therapy-specific side effects of aromatase inhibi-

therapy-specific side effects of aromatase inhibi-

Symposium Satellite HER2+ Early Breast Cancer Therapy:

Symposium Satellite HER2+ Early Breast Cancer Therapy:

Role Of Trastuzumab in HER2+ Breast Cancer. Importance of Combined Therapy

Role Of Trastuzumab in HER2+ Breast Cancer. Importance of Combined Therapy

patritumab selected for I-SPY 2 TRIAL in breast cancer.docx

patritumab selected for I-SPY 2 TRIAL in breast cancer.docx

N E W S Correction

N E W S Correction

TFG estherjimenezgimenez

TFG estherjimenezgimenez

ETUDES (CLINIQUE DU SEIN)

ETUDES (CLINIQUE DU SEIN)

A gene expression profile indicative of early stage Open Access